Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.22 EUR
70.32 M EUR
1.01 B EUR
53.42 M
About Embecta Corp.
Sector
Industry
CEO
Devdatt Kurdikar
Website
Headquarters
Parsippany
Founded
1924
FIGI
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of JX7 is 19.60 EUR — it has increased by 0.51% in the past 24 hours. Watch EMBECTA CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange EMBECTA CORPORATION stocks are traded under the ticker JX7.
JX7 stock has risen by 47.37% compared to the previous week, the month change is a 47.37% rise, over the last year EMBECTA CORPORATION has showed a 16.67% increase.
We've gathered analysts' opinions on EMBECTA CORPORATION future price: according to them, JX7 price has a max estimate of 18.91 EUR and a min estimate of 18.91 EUR. Watch JX7 chart and read a more detailed EMBECTA CORPORATION stock forecast: see what analysts think of EMBECTA CORPORATION and suggest that you do with its stocks.
JX7 stock is 3.11% volatile and has beta coefficient of 0.99. Track EMBECTA CORPORATION stock price on the chart and check out the list of the most volatile stocks — is EMBECTA CORPORATION there?
Today EMBECTA CORPORATION has the market capitalization of 1.14 B, it has decreased by −3.64% over the last week.
Yes, you can track EMBECTA CORPORATION financials in yearly and quarterly reports right on TradingView.
EMBECTA CORPORATION is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
JX7 earnings for the last quarter are 0.40 EUR per share, whereas the estimation was 0.33 EUR resulting in a 24.31% surprise. The estimated earnings for the next quarter are 0.42 EUR per share. See more details about EMBECTA CORPORATION earnings.
EMBECTA CORPORATION revenue for the last quarter amounts to 256.96 M EUR, despite the estimated figure of 248.76 M EUR. In the next quarter, revenue is expected to reach 240.77 M EUR.
JX7 net income for the last quarter is 13.11 M EUR, while the quarter before that showed 13.72 M EUR of net income which accounts for −4.45% change. Track more EMBECTA CORPORATION financial stats to get the full picture.
Yes, JX7 dividends are paid quarterly. The last dividend per share was 0.13 EUR. As of today, Dividend Yield (TTM)% is 2.88%. Tracking EMBECTA CORPORATION dividends might help you take more informed decisions.
EMBECTA CORPORATION dividend yield was 4.26% in 2024, and payout ratio reached 44.78%. The year before the numbers were 3.99% and 49.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EMBECTA CORPORATION EBITDA is 291.09 M EUR, and current EBITDA margin is 29.24%. See more stats in EMBECTA CORPORATION financial statements.
Like other stocks, JX7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EMBECTA CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EMBECTA CORPORATION technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EMBECTA CORPORATION stock shows the buy signal. See more of EMBECTA CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.